OSLO, Norway, Nov. 22, 2021 /PRNewswire/ -- ASA (OSE:
PHO), The Bladder Cancer Company, announces
that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer,
Erik Dahl will present a corporate
overview and host 1-on-1 meetings with investors at the Piper
Sandler 33rd Annual Healthcare conference, being
held virtually November 29 through December
2, 2021.
A webcast of the presentation will be made available in the
Congresses and Events section of Photocure's website at
https://photocure.com/investor/congresses--events/.
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative
solutions to improve the lives of bladder cancer patients. Our
unique technology, making cancer cells glow bright pink, has led to
better health outcomes for patients worldwide. Photocure is
headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange (OSE: PHO). For more information,
please visit us at www.photocure.com, www.hexvix.com,
www.cysview.com
CONTACT:
For further information, please
contact:
Dan Schneider
President and CEO
Photocure ASA
Email: ds@photocure.com
Erik Dahl
CFO
Photocure ASA
Tel: +4745055000
Email: ed@photocure.com
David Moskowitz
Head of Investor Relations
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/photocure/r/photocure-to-participate-in-the-piper-sandler-33-rd--annual-healthcare-conference,c3457692
The following files are available for download:
|
https://mb.cision.com/Main/17498/3457692/1499362.pdf
|
Release
|
View original
content:https://www.prnewswire.com/news-releases/photocure-to-participate-in-the-piper-sandler-33rd-annual-healthcare-conference-301429709.html
SOURCE Photocure